Bloomberg Television9 min
CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says
Interview
- The retail pharmacy business projects three consecutive years of growth and aims to operate independently to leverage prior investments.
- Management does not anticipate pursuing pharmaceutical asset acquisitions, prioritizing the development of a standalone retail entity over expansion into that sector.
- Both the remaining CVS Health entity and the prospective spun-off retail company are forecast to maintain solid investment-grade credit ratings.
- The company intends to limit leverage on the retail business to ensure investment-grade capabilities are not compromised.
- The organization positions itself as the lowest-cost provider with a high-service model, expecting to succeed across varying marketplace conditions.
- While the corporate split will not eliminate regulatory challenges, it is designed to specifically address customer and payer requirements.
- Execution of the current strategic plan is expected to cover the next four to six quarters.
- David Joyner intends to continue leading the company, citing his long tenure and organizational commitment.